MAX
Company Analysis Profound Medical Corp.
1. Summary
Advantages
- Price (5.51 $) is less than fair price (7.13 $)
- The stock's return over the last year (-4.33%) is higher than the sector average (-48.05%).
Disadvantages
- Dividends (0%) are below the sector average (0.5%).
- Current debt level 3.34% has increased over 5 years from 1.63%.
- The company's current efficiency (ROE=46.51%) is lower than the sector average (ROE=100.19%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Profound Medical Corp. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 2.3% | -13.6% | -1.7% |
| 90 days | -32% | 0.6% | -6% |
| 1 year | -4.3% | -48% | 19.1% |
PROF vs Sector: Profound Medical Corp. has outperformed the "Healthcare" sector by 43.71% over the past year.
PROF vs Market: Profound Medical Corp. has significantly underperformed the market by -23.39% over the past year.
Stable price: PROF is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: PROF with weekly volatility of -0.0833% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (5.51 $) is lower than the fair price (7.13 $).
Price significantly below the fair price: The current price (5.51 $) is 29.4% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (4.1) is lower than that of the sector as a whole (28.18).
P/E vs Market: The company's P/E (4.1) is higher than that of the market as a whole (-87.91).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.91) is lower than that of the sector as a whole (238.73).
P/BV vs Market: The company's P/BV (1.91) is lower than that of the market as a whole (81.51).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (10.78) is lower than that of the sector as a whole (149.95).
P/S vs Market: The company's P/S indicator (10.78) is lower than that of the market as a whole (116.07).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.58) is higher than that of the sector as a whole (-20.87).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.58) is higher than that of the market as a whole (-78.96).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -47.57% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-47.57%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-24.38%).
6.4. ROE
ROE vs Sector: The company's ROE (46.51%) is lower than that of the sector as a whole (100.19%).
ROE vs Market: The company's ROE (46.51%) is higher than that of the market as a whole (22.94%).
6.6. ROA
ROA vs Sector: The company's ROA (21.93%) is higher than that of the sector as a whole (-8.97%).
ROA vs Market: The company's ROA (21.93%) is higher than that of the market as a whole (3.9%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is higher than that of the sector as a whole (-0.11%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.79%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
